Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5879264 | The Journal of Pain | 2014 | 8 Pages |
Abstract
Pretreatment pain was an independent predictor of survival in a large sample of HNSCC patients even after accounting for tumor node metastasis stage, fatigue, age, race/ethnicity, smoking, and alcohol intake. Therefore, symptoms at presentation and before cancer treatment are important factors to be considered in understanding survival outcomes in HNSCC patients.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Cielito C. Reyes-Gibby, Karen O. Anderson, Kelly W. Merriman, Knox H. Todd, Sanjay S. Shete, Ehab Y. Hanna,